May 12, 2020 / 10:01 PM / 15 days ago

BRIEF-Arcutis Posts Q1 Loss Per Share Of $1.15

May 12 (Reuters) - Arcutis Biotherapeutics Inc:

* ARCUTIS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $1.15

* Q1 EARNINGS PER SHARE ESTIMATE $-0.92 — REFINITIV IBES DATA

* ARCUTIS CURRENTLY EXPECTS NO IMPACT TO ITS PREVIOUSLY DISCLOSED CLINICAL TIMELINES DUE TO COVID-19

* ARCUTIS BIOTHERAPEUTICS - BELIEVES CURRENT CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES, WILL BE SUFFICIENT TO FUND OPERATIONS THROUGH 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below